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suMMARy – A case is presented of a 59-year-old male patient with a 5-year history of sar-
coidosis. in the last half a year, deterioration of his intellectual abilities was noticed. psychological 
testing detected a mild cognitive disorder. laboratory diagnostics found a decreased level of testo-
sterone and magnetic resonance imaging showed pituitary stalk neurosarcoidosis without any other 
pathomorphological substrate of cognitive impairment. This case indicates that neurosarcoidosis 
should be considered as a possible cause of mild cognitive disorder and, consequently, included in 
the international Classification of Mental and Behavioural disorders.
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Introduction
sarcoidosis is a multisystemic granulomatous dis-
ease of unknown etiology. in 90% of patients, the 
disease affects the lungs, most commonly as bilateral 
lymphadenopathy. sarcoidosis can also involve other 
organs such as lymph nodes, eyes, skin, heart, mus-
cles, liver and brain1-14.
neurosarcoidosis (central and peripheral) can 
be found in 5%-15% of patients with sarcoidosis, 
whereas central neurosarcoidosis occurs in about 5% 
of patients. diagnosis of neurosarcoidosis is based on 
the clinical picture of sarcoidosis in other parts of the 
body (lung, liver, etc.), magnetic resonance imaging 
(MRi) of the brain, finding of angiotensin converting 
enzyme (ACe) in serum and liquor, and x-ray, but de-
finitive diagnosis can only be made after biopsy14-20.
previous research has shown that MRi helps in 
differentiating sarcoidosis from other brain diseases 
such as vasculitis, neoplasms (glioma, meningeoma, 
metastases) and other granulomatous diseases. it is 
important to distinguish neurosarcoidosis from non-
neoplastic diseases of the central nervous system, such 
as multiple sclerosis, stroke, pyogenic abscess, toxo-
plasmosis, tuberculosis, cysticercosis, fungal infec-
tions, syphilis, Behcet disease, radiation necrosis, ve-
nous thrombosis, but also manifestations of systemic 
lupus erythematosus, Henoch-schönlein purpura, 
polyarteritis nodosa, Wegener’s granulomatosis, etc.20-
23. in this case report, we describe a patient with pitu-
itary stalk neurosarcoidosis, which presented itself as 
a mild cognitive disorder.
Case Report
A 59-year-old man diagnosed with lung sarcoido-
sis five years before was treated with corticosteroids 
during the first year and a half after the diagnosis, but 
in the last three and a half years he received no thera-
py. during the last 6 months, his family members and 
friends noticed that his thoughts were slowed down 
and that sometimes he had difficulties in remember-
ing things. Therefore, he was referred for neurologi-
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cal, neuroradiological and hormonal examination, as 
well as psychological testing. on clinical neurological 
examination, no motor deficit was found. given the 
existing underlying disease, further diagnostic proce-
dures were undertaken. physical examination detected 
no enlarged lymph nodes, ACe in serum and liquor 
was increased; serum ACe was 127 iu/l (reference 
range: 8-51 iu/l) and ACe in the liquor finding was 
positive; computerized tomography (Ct) of the chest 
showed lesions characteristic of sarcoidosis: bilateral 
enlarged hilar lymph nodes, enlarged hilar and medi-
astinal lymph nodes with peribronchovascular thick-
ening and thickening of interlobular septa with nodal 
lesions connected to the pleura, consistent with the 
Fig. 1. Axial chest computed tomography without 
contrast media administration showed enlarged hilar 
and mediastinal lymph nodes. Peribronchovascular and 
interlobar septa are thick with nodal lesions connected 
to the pleura, corresponding to the lymphoid type of 
distribution in parenchymal sarcoidosis. There are signs 
of fibrosis within the lower lung lobes (not seen in these 
images).
Fig. 2. Lung computerized tomography shows bilateral 
lymphadenopathy.
Fig. 3. Brain magnetic resonance image: coronal post 
contrast T1 weighted image demonstrating abnormally 
thickened pituitary stalk.
Fig. 4. Brain magnetic resonance image: on the sagittal 
post contrast T1 weighted image, abnormally thickened 
pituitary stalk is confirmed, with very tiny hypophysis 
pushed down and posteriorly by a mild suprasellar 
cerebrospinal fluid herniation.
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lymphoid type of distribution in parenchymal sarcoi-
dosis (figs. 1 and 2).
signs of initial fibrosis were found in the lower 
lung lobes (not shown in the images). Ct of the neck 
was normal and showed no enlarged lymph nodes. 
Brain MRi revealed pituitary stalk neurosarcoidosis 
(figs. 3 and 4).
Hormonal examination showed normal levels of 
t3, t4, tsH and growth hormone, whereas serum 
testosterone concentration was lowered (table 1). psy-
chological examination detected psychomotor deteri-
oration, memory losses and learning difficulties. psy-
chological testing showed a decrease in the efficacy in 
the tests of learning and remembering, as well as some 
cognitive deterioration. visual-motor coordination 
and constructional functions were normal. scores on 
the tests for solving complex visual-spatial tasks were 
within the acceptable limits, but with certain devia-
tions indicative of cerebral dysfunction. Most promi-
nent failures were detected in the tests of acquiring 
new verbal content, while memory functions were 
moderately affected. verbal fluency tested by naming 
familiar objects was also subnormal. The speed of vi-
sual content processing was mildly to moderately de-
creased. non-verbal memory was also somewhat be-
low the average. flexibility of thinking was reduced 
(table 2). The above findings were indicative of a mild 
cognitive disorder. six months after the therapeutic 
treatment, the findings partly normalized, and cog-
nitive functions showed somewhat lesser deviations. 
serum ACe was mildly raised and serum testosterone 
was mildly lowered. neuropsychological tests showed 
signs of cognitive function improvements consistent 
with mild cognitive disorder.
Discussion
A number of clinical manifestations of neuro-
sarcoidosis have been described14-22. primarily, one 
should differentiate between central and peripheral 
neurosarcoidosis. peripheral neurosarcoidosis presents 
itself as polyneuropathy, myopathy, multiple monon-
euritis, and also affects peripheral and cranial nerve 
roots. Central neurosarcoidosis involves multiple or 
solitary supra- and infratentorial brain lesions, mostly 
in the hypothalamus and/or pituitary gland, pitu-
itary stalk, basal ganglia, multiple lacunar infarctions, 
fourth ventricles, inflammatory lesions in the brain 
and spinal cord, dural and leptomeningeal enhance-
ment, intracranial hemorrhage, pituitary tubercu-
loma, amygdale, anterior hippocampus, mesial tem-
poral neocortex, medullary involvement, deep white 
matter, cerebral aqueduct with hydrocephalus, pons, 
spinal mass lesion, temporodorsal in the hemisphere 
and cranial nerves17,19,24-54. ‘Aqueductal stenosis’ is 
commonly associated with psychosis and delirium in 
patients with neurosarcoidosis19,55.
serum hormone level serum hormone reference range
t3 2.1 mmol/l 1.3-3.6 mmol/l
t4 98 mmol/l 58-161 mmol/l
tsH 3.2 miu/l 0.3-3.6 miu/l
growth hormone 4.8 miu/l <10 miu/l
testosterone 2.8 nmol/l 4.6-21.7 nmol/l
Table 1. Hormone levels in the male patient with 
neurosarcoidosis
Neuropsychological test Test result
Memory losses
learning difficulties
test of learning and 
remembering                                     decreased
visual-motor coordination                         normal
Constructional functions                          normal
Complex visual-spatial tasks               subnormal
new verbal content                              prominent failures
Memory functions                                                             Moderately affected
verbal fluency tested                             subnormal
visual content processing                         decreased
non-verbal memory                              somewhat below the average
flexibility of thinking                            Reduced
Table 2. Neuropsychological tests in the male patient with 
neurosarcoidosis
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pituitary gland involvement caused by granuloma-
tous changes in the hypothalamo-hypophyseal system 
results in hormonal disbalance, which is responsible 
for diabetes insipidus as well as for amenorrhea-
galactorrhea with hypogonadotropic hypogonad-
ism16,26,34,36,38,42,44,49,50.
Brain MRi reveals changes in the pituitary gland 
and especially in the pituitary stalk that is often thick-
ened, which is quite characteristic of neurosarcoidosis. 
However, thickening of the pituitary stalk can occur 
in other diseases such as langerhans cell histiocytosis 
and pituitary hypophysitis26,34,44.
This case report describes a man with visible 
changes in pituitary stalk, as detected by MRi, ac-
companied by the lowered level of testosterone and 
impairment of cognitive function, i.e. mild cognitive 
disorder consisting of concentration difficulties and 
some degree of memory and psychomotor deteriora-
tion.
The lowered level of testosterone can be explained 
by the pituitary stalk damage.
The new, 10th, revision of the international Clas-
sification of Mental and Behavioural disorders (iCd-
10) contains mild cognitive disorders56. Mild cognitive 
disorder is diagnosed on the basis of neuroradiological 
and laboratory findings, and psychological testing, af-
ter all other possible causes have been ruled out.
neuropsychological impairments (psychomotor 
slowing, weakened memory, etc.) in mild cognitive 
disorder are not confirmed by morphological sub-
strates in the brain detected by the neuroradiological 
diagnostics (Ct and MRi). definitive diagnosis of 
neurosarcoidosis in our patient was made on the basis 
of lung x-ray, ACe in serum and liquor, neuroradio-
logical examination and psychological testing which, 
together with clinical symptoms, indicated mild cog-
nitive disorder. in our patient, neurosarcoidosis of the 
pituitary stalk could explain the lowered level of tes-
tosterone, but could not be associated with cognitive 
impairments. in the case presented, we found no mor-
phological substrate that could explain the mild cog-
nitive disorder. prüter et al. have previously described 
a mild cognitive disorder with no clear morphologi-
cal substrate found on MRi in a woman with sarcoi-
dosis, which they explained by meningitis caused by 
neurosarcoidosis57. in our case, there were no signs of 
meningitis or any other inflammatory process in the 
central nervous system during the course of illness. 
prüter et al. state that neurosarcoidosis in most cases 
occurs as a subacute form of sarcoidosis57. obviously, 
in our case neurosarcoidosis developed in a subacute 
phase, when bilateral hilar lymphadenopathy was in 
regression.
in the male patient, pituitary stalk neurosarcoido-
sis resulted in a lowered level of testosterone, whereas 
hyperprolactinemia and amenorrhea are described in 
female patients26,44,58,59. similar to the previously de-
scribed case57, mild cognitive disorder found in our 
patient did not have a clear morphological substrate. 
studies have shown that in most of the patients with 
mild cognitive disorder caused by other etiological 
factors there is no clear pathomorphological substrate 
detectable by standard neuroradiological diagnostics. 
An exception is MRi 3t, which allows recognizing 
some differences in comparison to control group60,61.
in conclusion, pituitary stalk neurosarcoidosis in 
men can present itself with a low level of testoster-
one, but also as a mild cognitive disorder. since this is 
the second case of mild cognitive disorder reported in 
patients with neurosarcoidosis, we suggest that neu-
rosarcoidosis should be considered as a possible cause 
of mild cognitive disorder and, consequently, included 
in the international Classification of Mental and Be-
havioural disorders.
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sažetak
BlAži kognitivni poReMeĆAJ kAo kliniČkA MAnifestACiJA neuRosARkoidoZe liJevkA 
HipofiZe: pRikAZ sluČAJA
M. Titlić, K. Dolić i N. Bešenski
prikazuje se slučaj 59-godišnjeg bolesnika s 5-godišnjom poviješću bolesti sarkoidoze. u posljednjih pola godine pri-
mjetno je bilo slabljenje njegovih intelektualnih sposobnosti. psihološkim testiranjem otkriven je blaži spoznajni pore-
mećaj. laboratorijskom dijagnostikom utvrđena je snižena razina testosterona, dok je magnetska rezonancija pokazala 
neurosarkoidozu lijevka hipofize bez ikakvog drugog patomorfološkog supstrata kognitivnog poremećaja. ovaj slučaj po-
kazuje da neurosarkoidozu treba uzeti u obzir kao mogući uzrok blažeg spoznajnog poremećaja, pa bi je trebalo uvrstiti u 
Međunarodnu klasifikaciju psihičkih bolesti i bolesti ponašanja.
ključne riječi: Neurosarkoidoza; Hipofiza; Kognitivni poremećaji

